This brief opening will frame the day’s program and introduce the four “Dynamic Shifts” that define this year’s AIS format. Attendees will gain a clear view of the themes shaping today’s aesthetics landscape and how the sessions ahead connect to the broader industry narrative.

This presentation will explore what durable growth truly looks like in today’s evolving aesthetics market, with a focus on innovation that drives meaningful clinical outcomes, strengthens patient loyalty, and creates sustainable differentiation. The session will set the tone for the day, offering a grounded, long-term view of growth that extends beyond short-term market cycles.

This live podcast recording offers a candid, behind-the-scenes conversation focused on leadership, strategy, and innovation in aesthetics. Expect thoughtful discussion on navigating market complexity, evolving portfolios, and building momentum in a rapidly changing industry.

This session highlights the pipeline transformation underway as aesthetics moves from synthetic solutions toward biological, autologous, and regenerative therapies. With advances in cell-based treatments, biopolymers, tissue-derived products, and combination approaches, the field is rapidly shifting toward interventions that restore, rebuild, and rejuvenate rather than simply fill or mask. This session explores where innovation is heading, the scientific and clinical breakthroughs driving the next decade, and what this evolution means for safety, outcomes, and the long-term future of aesthetic medicine.

This rapid-fire session highlights emerging regenerative technologies shaping the future of aesthetic medicine. Participating companies will showcase novel approaches spanning biologics, tissue-based solutions, and combination therapies aimed at improving outcomes and durability.

This session will explore the emergence of the “new aesthetic patient,” shaped by generational change, the influence of GLP-1s, and a strong move toward natural, lower-cost, and wellness-aligned treatments. Today’s consumers are shifting away from the over-filled look, forcing a re-evaluation of HA filler strategies, and body contouring demand has evolved from fat-freezing to skin tightening and post–weight-loss solutions. Experts will unpack how these trends are redefining patient expectations, practice models, and treatment pathways for 2025 and beyond.

This session features innovative tools and platforms designed to modernize the patient journey, from acquisition and personalization to engagement and retention. Presentations will focus on practical solutions helping practices adapt to changing patient expectations and behaviors.

This focused presentation examines how artificial intelligence is beginning to reshape aesthetic medicine, from personalization and imaging, to decision support and operational efficiency. Attendees will gain insight into where AI is delivering value today and where it is headed next.

This session explores strategies and technologies aimed at improving skin quality, barrier health, and long-term outcomes. Presentations will span injectable, topical, device-based, and regenerative approaches that support comprehensive skin health optimization.

This session explores the evolution of holistic aesthetics, where patient expectations now extend far beyond traditional cosmetic treatments and toward whole-patient wellness, inside and out. With more than 60% of clinics offering adjacent services such as GLP-1s, HRT, peptides, and sexual wellness, the aesthetic landscape is rapidly expanding into metabolic, hormonal, and lifestyle care. This session examines how these new integrative treatment pathways are reshaping practice models and patient outcomes, while spotlighting the growing regulatory implications that accompany this shift, ranging from medical oversight and scope of practice to marketing, safety, and compliance in a hybrid wellness–aesthetics environment.

This fast-paced showcase highlights breakthrough products and technologies across aesthetics. Companies will present what’s new, what’s coming next, and how their innovations address unmet needs in an increasingly competitive market.

Four companies will give six minute presentations to a group of sharks. Each presentation will be followed by five minutes of Q&A from the sharks.

This session examines the economic forces reshaping aesthetics from macro pressures like tariffs, consolidation, and tightening capital markets to micro-level realities such as consumer spend tolerance and the rise of membership models within practices. With PE and VC investment priorities shifting and practice roll-ups accelerating, this segment explores how financial dynamics are influencing product strategies, pricing, and access to care. How do these economic changes ultimately impact patient care and the sustainability of aesthetic practices?